1. Home
  2. AGRZ vs GNPX Comparison

AGRZ vs GNPX Comparison

Compare AGRZ & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AGRZ

Agroz Inc. Ordinary Shares

N/A

Current Price

$0.42

Market Cap

14.5M

ML Signal

N/A

Logo Genprex Inc.

GNPX

Genprex Inc.

HOLD

Current Price

$1.03

Market Cap

11.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGRZ
GNPX
Founded
2020
2009
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
11.8M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
AGRZ
GNPX
Price
$0.42
$1.03
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
446.9K
581.2K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.14
52 Week High
$7.20
$12.97

Technical Indicators

Market Signals
Indicator
AGRZ
GNPX
Relative Strength Index (RSI) 45.25 24.78
Support Level $0.33 $0.17
Resistance Level $0.61 $2.12
Average True Range (ATR) 0.05 0.13
MACD -0.00 -0.02
Stochastic Oscillator 38.98 1.79

Price Performance

Historical Comparison
AGRZ
GNPX

About AGRZ Agroz Inc. Ordinary Shares

Agroz Inc is a vertically integrated agricultural technology (AgTech) company focused on designing, innovating, developing, building, operating and managing large, commercial-scale, industrial-grade indoor CEA vertical farms using CEA practices. Its mission is to improve food safety, food security, and sustainability for society by creating a reliable, accessible food supply through its AgTech products and services. CEA vertical farming is an agricultural method involving crop cultivation through vertically stacked layers in a controlled indoor environment. CEA practices are defined by growing produce in spaces where environmental conditions can be controlled and manipulated to match the needs of specific plants.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).

Share on Social Networks: